Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WT1 antisense RNA (WT1-AS) is a long non-coding RNA located on human chromosome 11, transcribed antisense to the Wilms tumor 1 (WT1) gene[1][8]. Unlike the WT1 protein, WT1-AS does not code for a protein; instead, it regulates gene expression at the RNA level, predominantly by negatively regulating the expression of the WT1 gene[1][3][5]. It is functionally imprinted in the human kidney, where only the paternal allele is expressed. WT1-AS acts as a tumor suppressor in various human cancers, including gastric, lung, and cervical tumors; its dysregulation has been connected to increased proliferation, migration, stemness, and reduced apoptosis of tumor cells. Upregulation of WT1-AS can inhibit cancer cell growth and metastasis, and its promoter methylation status has been linked to prognosis in some cancers[3][5]. No clinically approved drugs currently target WT1-AS, and its primary significance is in non-coding RNA biology and as a cancer biomarker[3][5][9].
Functions through antisense inhibition of WT1 gene transcription and post-transcriptional repression; no drug-targeted mechanisms established
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WT1 antisense RNA (WT1-AS).